Thomas Szymanski, PharmD
Advertisement
Thomas Szymanski is PGY1 resident at Memorial Hermann-Texas Medical Center in Houston, TX. He earned his PharmD and a BA in French from the University of Rhode Island. His professional interests include cardiology and critical care. Thomas is an active member of ASHP and ACCP and has served on various national committees and advisory groups.
Articles by Thomas Szymanski, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
New Research Suggests Bempedoic Acid Outperforms Ezetimibe for Heart Health in Patients with Type 2 Diabetes
4
ADA 2026: Why Some T2D Patients Don't Respond to GLP-1 RAs—And What Pharmacists Should Screen For
5